Skip to main content

Cytokine Marker Measurement in Human Neuroblastoma Cells with Supersensitive and Multiplex Assay: MUSTag Technology

  • Conference paper
  • First Online:
Brain Edema XV

Abstract

Background: Recently, various sets of protein ­biomarkers have been discovered in important diseases such as cancers, brain stroke and heart attack. However, clinical validation is difficult and time-consuming by individual assays or because of very low concentrations at early stages of the diseases. We have developed assay technology through an innovative modification of the immuno-PCR method for the super-sensitive and multiplex detection of target biomarkers.

Methods: In the assay technology, each different oligo-tag simultaneously detects multiplex protein targets with extremely high-level sensitivity in a dose-dependent manner by qRT-PCR (maximum: three plexes). In this study, we measured specific secreted protein concentrations in the culture supernatant of a 24-h culture of transfected SH-SY5Y cells with MUSTag.

Results: There was a significant increase in the protein level of tumor necrosis factor (TNF)-α measured with extremely high-level sensitivity (≥10 pg/mL). Compared with negative controls, the levels of TNF-α increased from 16.9 to 28.1 pg/mL (p = 0.011).

Conclusion: We suggest that our assay technology might be of clinical value in treating patients with cancer, cerebral ischemia, or patients who need a prompt and predictive diagnosis for adequate treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Asano K, Merrick WC, Hershey JW (1997) The translation ­initiation factor eIF3-p48 subunit is encoded by int-6, a site of frequent integration by the mouse mammary tumor virus genome. J Biol Chem 272(38):23477–23480

    Article  PubMed  CAS  Google Scholar 

  2. Banks RE, Dunn MJ, Hochstrasser DF, Sanchez JC, Blackstock W, Pappin DJ, Selby PJ (2000) Proteomics: new perspectives, new biomedical opportunities. Lancet 356(9243):1749–1756

    Article  PubMed  CAS  Google Scholar 

  3. Chen L, Uchida K, Endler A, Shibasaki F (2007) Mammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulation. J Biol Chem 282(17):12707–12716

    Article  PubMed  CAS  Google Scholar 

  4. Chen L, Endler A, Uchida K, Horiguchi S, Morizane Y, Iijima O, Toi M, Shibasaki F (2010) Int6/eIF3e Silencing promotes functional blood vessel outgrowth and enhances wound healing by upregulating hypoxia-induced factor 2alpha expression. Circulation 122(9):910–919

    Article  PubMed  CAS  Google Scholar 

  5. Kingsmore SF (2006) Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov 5(4):310–320

    Article  PubMed  CAS  Google Scholar 

  6. Marchetti A, Buttitta F, Miyazaki S, Gallahan D, Smith GH, Callahan R (1995) Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J Virol 69(3):1932–1938

    PubMed  CAS  Google Scholar 

  7. Shibasaki F, Morizane Y, Ishikawa Y, Makisaka N, Komata Y, Chen L, Uchida K (2008) Clinical application of supersensitive and multiplex assay, MUSTag technology. Rinsho Byori 56(9):802–810

    PubMed  CAS  Google Scholar 

  8. Shibasaki F, Morizane Y, Makisaka N (2009) Protein biomarker measurement and simple/rapid diagnostics with supersensitive and multiplex assay, MUSTag technology. Rinsho Byori 57(11):1104–1112

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are grateful to A. Sakurai, T. Hashimoto, and A. Endler for suggestions and critical reading of the manuscript; N. Makisaka for technical assistance; and all the members of our laboratory for their input during the course of this work.

Conflict of InterestWe declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ryoichi Miyashita .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Wien

About this paper

Cite this paper

Miyashita, R. et al. (2013). Cytokine Marker Measurement in Human Neuroblastoma Cells with Supersensitive and Multiplex Assay: MUSTag Technology. In: Katayama, Y., Maeda, T., Kuroiwa, T. (eds) Brain Edema XV. Acta Neurochirurgica Supplement, vol 118. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1434-6_62

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-1434-6_62

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-1433-9

  • Online ISBN: 978-3-7091-1434-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics